{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T20:21:08Z","timestamp":1775766068584,"version":"3.50.1"},"reference-count":6,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1097\/ico.0b013e318166f483","type":"journal-article","created":{"date-parts":[[2008,5,22]],"date-time":"2008-05-22T07:10:23Z","timestamp":1211440223000},"page":"612-614","source":"Crossref","is-referenced-by-count":62,"title":["Persisting Corneal Erosion Under Cetuximab (Erbitux) Treatment (Epidermal Growth Factor Receptor Antibody)"],"prefix":"10.1097","volume":"27","author":[{"given":"Claudia G","family":"Foerster","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claus","family":"Cursiefen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Friedrich E","family":"Kruse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20-20210204","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/sj.bjc.6603018","article-title":"Cetucimab and irinotecan as third-line therapy in advanced colorectal cancer patients: a single centre phase II trial.","volume":"94","author":"Vicenzi","year":"2006","journal-title":"Br J Cancer"},{"key":"R2-20-20210204","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.3816\/CCC.2005.s.003","article-title":"Epidermal growth factor receptor as a target for chemotherapy.","volume":"1","author":"Vallbohmer","year":"2005","journal-title":"Clin Colorectal Cancer"},{"key":"R3-20-20210204","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1056\/NEJMoa033025","article-title":"Cetuximab monotherapy and cetuxima plus irinotecan in irinotecan-refractory metastatic colorectal cancer.","volume":"351","author":"Cunningham","year":"2004","journal-title":"N Engl J Med"},{"key":"R4-20-20210204","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1093\/annonc\/mdi300","article-title":"Trichomegaly of the eyelashes following treatment with Cetuximab.","volume":"16","author":"Bouche","year":"2005","journal-title":"Ann Oncol"},{"key":"R5-20-20210204","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/00003226-200101000-00016","article-title":"Expression of the receptor tyrosine kinases, epidermal growth factor receptor, ErbB2 and ErbB3 in human ocular surface epithelia.","volume":"20","author":"Liu","year":"2001","journal-title":"Cornea"},{"key":"R6-20-20210204","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0014-4835(73)90151-6","article-title":"Proliferation of corneal epithelium.","volume":"15","author":"Savage","year":"1973","journal-title":"Exp Eye Res"}],"container-title":["Cornea"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00003226-200806000-00020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T01:41:15Z","timestamp":1618278075000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003226-200806000-00020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":6,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/ico.0b013e318166f483","relation":{},"ISSN":["0277-3740"],"issn-type":[{"value":"0277-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}